1.
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
by Liang, Wenhua
The lancet oncology, 2020, Vol.21 (3), p.335-337
2.
Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and document...
by White, Jane V
Journal of the Academy of Nutrition and Dietetics, 2012, Vol.112 (5), p.730
3.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
by Khoury, David S
Nature medicine, 2021, Vol.27 (7), p.1205-1211
4.
Thyroid cancer
by Cabanillas, Maria E, Dr
The Lancet (British edition), 2016, Vol.388 (10061), p.2783-2795
5.
An inflammatory cytokine signature predicts COVID-19 severity and survival
by Del Valle, Diane Marie
Nature medicine, 2020, Vol.26 (10), p.1636-1643
6.
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
by Cross, Marita
Annals of the rheumatic diseases, 2014, Vol.73 (7), p.1316-1322
7.
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
by Thevarajan, Irani
Nature medicine, 2020, Vol.26 (4), p.453-455
8.
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
by Paramsothy, Sudarshan, MD
The Lancet (British edition), 2017, Vol.389 (10075), p.1218-1228
9.
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
by Tian, Jianbo
The lancet oncology, 2020, Vol.21 (7), p.893-903
10.
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
by Smolen, Josef S Josef S
Annals of the rheumatic diseases, 2015, Vol.75 (1), p.3-15
11.
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
by Banks, Peter A
Gut, 2013, Vol.62 (1), p.102-111
12.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-infer...
by Jørgensen, Kristin K, PhD
The Lancet (British edition), 2017, Vol.389 (10086), p.2304-2316
13.
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
by Liu, Sean T H
Nature medicine, 2020, Vol.26 (11), p.1708-1713
14.
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
by Wu, Joseph T
Nature medicine, 2020, Vol.26 (4), p.506-510
15.
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
by Cross, Marita
Annals of the rheumatic diseases, 2014, Vol.73 (7), p.1323-1330
16.
Real-time tracking of self-reported symptoms to predict potential COVID-19
by Menni, Cristina
Nature medicine, 2020, Vol.26 (7), p.1037-1040
17.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
by Yang, Kunyu
The lancet oncology, 2020, Vol.21 (7), p.904-913
18.
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging p...
by Thaçi, Diamant, Prof
The Lancet (British edition), 2016, Vol.387 (10013), p.40-52
19.
A dynamic COVID-19 immune signature includes associations with poor prognosis
by Laing, Adam G
Nature medicine, 2020, Vol.26 (10), p.1623-1635
20.
Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
by The AVERT Trial Collaboration group
The Lancet (British edition), 2015, Vol.386 (9988), p.46-55
